Inspirna, Inc.(formerly Rgenix, Inc.): Funding & Investors (Oct 2026)
Inspirna (previously Rgenix) is a clinical-stage biopharmaceutical organization growing first-in-class/top tier drug up-and-comers that target basic disease drivers. Our disclosure stage use RNA science to find novel RNA dysregulated malignant growth drivers that can be designated by little atoms and biologics. Clinical projects are first-in-class oral little particles being developed for patients with RAS freak CRC (RGX-202; Phase 1b) as well as SCLC and NSCLC (RGX-104; Phase 1b/2)
Inspirna, Inc.(formerly Rgenix, Inc.) has raised $50.0M across 1 funding round on record, the most recent a Series D of $50.0M announced in Jul 2022.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Inspirna, Inc.(formerly Rgenix, Inc.) Company Profile and Key Stats
Latest funding round on record: Jul 2022.
Inspirna, Inc.(formerly Rgenix, Inc.) Funding Rounds
Inspirna, Inc.(formerly Rgenix, Inc.) Founders and Leadership Team
No contact details are on record for this team yet.
Inspirna, Inc.(formerly Rgenix, Inc.) Funding Compared to Other Biotechnology Startups
Inspirna, Inc.(formerly Rgenix, Inc.)'s latest round of $50.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Inspirna, Inc.(formerly Rgenix, Inc.) in Biotechnology and New York
Companies Similar to Inspirna, Inc.(formerly Rgenix, Inc.)
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Inspirna, Inc.(formerly Rgenix, Inc.) Funding FAQs
What does Inspirna, Inc.(formerly Rgenix, Inc.) do?
Inspirna (previously Rgenix) is a clinical-stage biopharmaceutical organization growing first-in-class/top tier drug up-and-comers that target basic disease drivers. Our disclosure stage use RNA science to find novel RNA dysregulated malignant growth drivers that can be designated by little atoms and biologics. Clinical projects are first-in-class oral little particles being developed for patients with RAS freak CRC (RGX-202; Phase 1b) as well as SCLC and NSCLC (RGX-104; Phase 1b/2)
How much funding has Inspirna, Inc.(formerly Rgenix, Inc.) raised?
Inspirna, Inc.(formerly Rgenix, Inc.) has raised $50.0M across 1 round on record. The most recent is a Series D of $50.0M announced in Jul 2022.
When did Inspirna, Inc.(formerly Rgenix, Inc.) last raise funding?
Inspirna, Inc.(formerly Rgenix, Inc.)'s most recent funding round on record is a Series D of $50.0M, announced in Jul 2022.
Who is the CEO of Inspirna, Inc.(formerly Rgenix, Inc.)?
Masoud Tavazoie is listed as CEO at Inspirna, Inc.(formerly Rgenix, Inc.).
Where is Inspirna, Inc.(formerly Rgenix, Inc.) headquartered?
Inspirna, Inc.(formerly Rgenix, Inc.) is based in New York, United States.
How many employees does Inspirna, Inc.(formerly Rgenix, Inc.) have?
Inspirna, Inc.(formerly Rgenix, Inc.) is in the 11-50 employee band.
How does Inspirna, Inc.(formerly Rgenix, Inc.)'s funding compare to other Biotechnology startups?
Inspirna, Inc.(formerly Rgenix, Inc.)'s latest round of $50.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Inspirna, Inc.(formerly Rgenix, Inc.) Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Inspirna, Inc.(formerly Rgenix, Inc.) is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.